Schreiber elected AACR Academy fellow

Robert D. Schreiber, PhD, the Andrew M. and Jane M. Bursky Distinguished Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis, has been elected a fellow of the American Association for Cancer Research (AACR) Academy.

The academy recognizes “distinguished scientists whose major scientific contributions have propelled significant innovation and progress against cancer.”

Schreiber also is a professor of molecular microbiology and the founding director of the Bursky Center for Human Immunology and Immunotherapy Programs at the School of Medicine, and co-leader of the Tumor Immunology Program at Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine. He is noted for his research demonstrating that the immune system plays an important role in tumor development.

For more information on Schreiber’s research and career, visit:

• The warrior within: Immune-based therapies are becoming a reality for cancer care
• Schreiber awarded Balzan Prize for pioneering cancer research
• $10 million gift creates Bursky Center for Human Immunology and Immunotherapy
• $10.4 million awarded for pancreatic cancer research
  • Project 4: Translation and Preclinical Studies of a Personalized pancreas cancer vaccine
• Cancer researchers named to federal Moonshot committees